Location: Redwood City, CA
CIK: 0001582844 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $147M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 637,095 | $25.74M | 17.5% | $9.17 | +152.0% | COM | 880881107 |
| PRAX | PRAXIS PRECISION MEDICINES I | 83,036 | $24.47M | 16.6% | $95.33 | +95.4% | COM | 74006W207 |
| — | CIDARA THERAPEUTICS INC | 89,145 | $19.69M | 13.4% | $31.31 | — | COM NEW | 171757206 |
| OCUL | OCULAR THERAPEUTIX INC | 1,052,995 | $12.78M | 8.7% | $6.18 | +96.5% | COM | 67576A100 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 3,410,402 | $8.253M | 5.6% | $16.10 | -85.7% | COM | 00032Q104 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 84,477 | $6.593M | 4.5% | $36.75 | +81.9% | COM NEW | 10919W405 |
| CMPX | COMPASS THERAPEUTICS INC | 1,093,300 | $5.871M | 4.0% | $3.50 | +32.1% | COM | 20454B104 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 29,008 | $4.931M | 3.3% | $121.51 | +26.2% | SHS USD | G50871105 |
| INSM | INSMED INC | 25,878 | $4.504M | 3.1% | $47.04 | +287.9% | COM PAR $.01 | 457669307 |
| ARGX | ARGEN SE - ADR | 4,851 | $4.079M | 2.8% | $489.55 | — | SPONSORED ADR | 04016X101 |
| SRZN | SURROZEN INC | 178,415 | $4.032M | 2.7% | $11.57 | +39.8% | COM NEW | 86889P208 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 333,258 | $4.026M | 2.7% | $9.41 | +44.3% | COM | 03237H101 |
| NERV | MINERVA NEUROSCIENCES | 709,500 | $2.852M | 1.9% | $3.71 | 0.0% | COM NEW | 603380205 |
| TNGX | TANGO THERAPEUTICS INC | 282,732 | $2.505M | 1.7% | $8.62 | 0.0% | COM | 87583X109 |
| TSHA | TAYSHA GENE THERAPIES INC | 454,827 | $2.502M | 1.7% | $2.17 | +123.5% | COM SHS | 877619106 |
| ZYME | ZYMEWORKS INC | 80,143 | $2.11M | 1.4% | $13.60 | +60.4% | COM | 98985Y108 |
| OCS | OCULIS HOLDING AG | 101,777 | $2.032M | 1.4% | $20.50 | -2.4% | ORDINARY SHARES | H5870P102 |
| DSGN | DESIGN THERAPEUTICS INC | 150,906 | $1.415M | 1.0% | $7.83 | 0.0% | COM | 25056L103 |
| INBX | INHIBRX BIOSCIENCES INC | 16,377 | $1.294M | 0.9% | $24.62 | +176.8% | COM | 45720N103 |
| UTHR | UNITED THERAPEUTICS CORP | 2,296 | $1.119M | 0.8% | $336.31 | +38.5% | COM | 91307C102 |
| VSTM | VERASTEM INC | 143,446 | $1.107M | 0.8% | $6.11 | +45.9% | COM NEW | 92337C203 |
| MAZE | MAZE THERAPEUTICS INC | 20,000 | $829K | 0.6% | $34.37 | 0.0% | COM | 578784100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 59,280 | $781K | 0.5% | $11.80 | 0.0% | CLASS A ORD | 61559X104 |
| STRO | SUTRO BIOPHARMA INC | 67,451 | $780K | 0.5% | $9.49 | 0.0% | COM | 869367201 |
| DNTH | DIANTHUS THERAPEUTICS INC | 16,708 | $689K | 0.5% | $25.56 | +51.7% | COM | 252828108 |
| RVMD | REVOLUTION MEDICINES INC | 8,411 | $670K | 0.5% | $24.90 | +163.3% | COM | 76155X100 |
| LBRX | LB PHARMACEUTICALS INC | 30,000 | $668K | 0.5% | $15.87 | +10.1% | COM SHS | 50180M108 |
| KTTA | PASITHEA THERAPEUTICS CORP | 450,000 | $581K | 0.4% | $0.88 | 0.0% | COM NEW | 70261F202 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 59,985 | $346K | 0.2% | $6.18 | -13.7% | COM | 90466Y202 |
| — | NUVATION BIO INC -CW27 | 90,832 | $29,975 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |